Cancer of the pancreas and pancreatic cystic lesions
Chapter 13 CANCER OF THE PANCREAS AND PANCREATIC CYSTIC LESIONS KEY POINTS • Pancreatic cancer is an aggressive cancer with a low survival time: 10%–15% survival at 5 years. •…
Chapter 13 CANCER OF THE PANCREAS AND PANCREATIC CYSTIC LESIONS KEY POINTS • Pancreatic cancer is an aggressive cancer with a low survival time: 10%–15% survival at 5 years. •…
Chapter 12 CHRONIC PANCREATITIS KEY POINTS • Chronic pancreatitis, chronic inflammation of the pancreas, is characterised by progressive irreversible loss of pancreatic exocrine and endocrine function. • Chronic pancreatits manifests…
Chapter 10 FOOD ALLERGIES AND INTOLERANCES KEY POINTS • Food allergies may affect up to 6% of the population. • Food allergies are adverse reactions to foods mediated by the…
Chapter 8 HAEMATEMESIS AND MELAENA KEY POINTS • Resuscitation should be instituted irrespective of the underlying cause of gastrointestinal bleeding. • A multidisciplinary approach to management is key. • Patients…
Chapter 7 ACUTE ABDOMINAL PAIN KEY POINTS • Acute abdominal pain is usually a surgical condition. • Most conditions can be diagnosed by bedside assessment. • Clinical peritonitis will usually…
Chapter 4 DYSPEPSIA AND FUNCTIONAL DYSPEPSIA KEY POINTS • Dyspepsia is defined as pain or discomfort located in the central upper abdomen. • Dyspepsia may coexist with and be difficult…
Chapter 2 DYSPHAGIA AND ODYNOPHAGIA KEY POINTS • A careful history will yield the likely diagnosis in 80% of cases. • The site of bolus hold-up is not reliable if…
Chapter 5 NAUSEA AND VOMITING KEY POINTS • Nausea and vomiting are most often secondary to extra-gastrointestinal processes. • A systematic approach to diagnosis and management is imperative given the…
CHAPTER 6 MALIGNANT CONDITIONS INVOLVING THE OESOPHAGUS, STOMACH, SMALL INTESTINE, GALL BLADDER AND BILE DUCT KEYPOINTS • In upper gastrointestinal tumours, accurate preoperative staging is important in determining appropriate management….
Fig. 8.1 Patient with intra-abdominal sepsis and gut ischemia. While there is no EAF present, they are a prime candidate for this complication Fig. 8.2 Patient undergoing cytoreduction and HIPEC….